Improving Cancer Immunotherapy through Metabolic Modulation 2020 Emerging Leader Award Greg Delgoffe, PhD, The University of Pittsburgh Read More
Long-Range Tumor-Host Signaling Mechanisms Driving Paraneoplastic Syndromes 2020 Damon Runyon - Mark Foundation Postdoctoral Fellow Katy Ong, PhD, University of California, Berkeley Read More
Generating a Long-term Immune Response to Merkel Cell Carcinoma 2020 ASPIRE Award; 2022 ASPIRE II Award Paul Nghiem, MD, PhD, University of Washington Read More
Selectively Targeting Non-Proliferating Cancer Cells 2020 ASPIRE Award; 2022 ASPIRE II Award René Bernards, PhD, Netherlands Cancer Institute (Principal); Anthony Letai, MD, PhD, Dana-Farber Cancer Institute Read More
Targeting Chordoma Spinal Tumors Using Rational Drug Design 2020 Partnership with Chordoma Foundation David Drewry, PhD, University of North Carolina, Chapel Hill; Opher Gileadi, PhD, University of Oxford; Paul Workman, PhD, Institute for Cancer Research Read More
Using a High-Fiber Diet to Improve Melanoma Patients’ Response to Immunotherapy 2019 ASPIRE Award Jennifer McQuade, MD, MS (Principal); Jennifer Wargo, MD, MMSc; and Carrie Daniel-MacDougall, PhD, MPH, The University of Texas MD Anderson Cancer Center Read More
